Literature DB >> 23989943

Surgical strategies for esophageal cancer associated with head and neck cancer.

Masaru Morita1, Hiroshi Saeki, Shuhei Ito, Yasue Kimura, Nami Yamashita, Koji Ando, Yukiharu Hiyoshi, Eriko Tokunaga, Eiji Oki, Tetsuo Ikeda, Sei Yoshida, Torahiko Nakashima, Yoshihiko Maehara.   

Abstract

Esophageal cancer is frequently associated with squamous cell carcinoma in the head and neck. Both cigarette smoking and alcohol consumption are risk factors for multiple cancers of the head and neck, as well as the esophagus. Routine screening and close follow-up for second cancers are important in patients with esophageal cancer or head and neck cancer. For this purpose, endoscopy with Lugol's staining, as well as narrow-band imaging combined with magnifying endoscopy, is a powerful tool for the early detection of esophageal cancer. Multimodal therapy is essential for patients with double cancers. When considering surgical treatment, the curability of both cancers must be carefully evaluated. If both tumors are potentially curable, each lesion should be treated individually. In patients with metachronous double cancers, the prior treatment of the first primary carcinoma often affects the treatment of the second cancer. Close cooperation among medical staff members is essential for complicated surgeries for double cancers. Techniques that are appropriate for each case must be adopted, such as careful dissection, staged operations, muscular flaps and microvascular anastomosis.

Entities:  

Mesh:

Year:  2013        PMID: 23989943     DOI: 10.1007/s00595-013-0713-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  57 in total

1.  Sound spectrogram analysis in patients receiving Kawahara's surgical voice restoration for advanced carcinoma of the hypopharynx and cervical esophagus.

Authors:  S Motoyama; R Saito; K Maruyama; M Okuyama; K Sasaki; M Wako; A Kitamura; J Ogawa
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

2.  Free jejunal transfer for patients with a history of esophagectomy and gastric pull-up.

Authors:  Hirotaka Suga; Mutsumi Okazaki; Shunji Sarukawa; Akihiko Takushima; Hirotaka Asato
Journal:  Ann Plast Surg       Date:  2007-02       Impact factor: 1.539

3.  Esophagectomy and gastric pull-up in patients with previous free jejunal transfer.

Authors:  Yoshinori Hosoya; Shunji Sarukawa; Shiro Matsumoto; Toru Zuiki; Masanobu Hyodo; Koichi Abe; Hiroshi Nishino; Yasushi Sugawara; Alan T Lefor; Yoshikazu Yasuda
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

4.  Pharyngolaryngoesophagectomy using the thoracoscopic approach.

Authors:  H A Cense; S Law; W Wei; L-K Lam; W-M Ng; K-H Wong; K-F Kwok; J Wong
Journal:  Surg Endosc       Date:  2006-11-14       Impact factor: 4.584

5.  Two-stage operation for high-risk patients with thoracic esophageal cancer: an old operation revisited.

Authors:  Masaru Morita; Tomonori Nakanoko; Nobuhide Kubo; Yoshihiko Fujinaka; Keisuke Ikeda; Akinori Egashira; Hiroshi Saeki; Hideaki Uchiyama; Takefumi Ohga; Yoshihiro Kakeji; Ken Shirabe; Tetsuo Ikeda; Shunichi Tsujitani; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2011-03-16       Impact factor: 5.344

6.  Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.

Authors:  Chikatoshi Katada; Manabu Muto; Meijin Nakayama; Satoshi Tanabe; Katsuhiko Higuchi; Tohru Sasaki; Mizutomo Azuma; Kenji Ishido; Natsuya Katada; Keishi Yamashita; Masayuki Nemoto; Tomotaka Shibata; Takashi Masaki; Makito Okamoto; Wasaburo Koizumi
Journal:  Laryngoscope       Date:  2012-06       Impact factor: 3.325

7.  Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?

Authors:  Emmanuel Guardiola; Xavier Pivot; Olivier Dassonville; Gilles Poissonnet; Pierre-Yves Marcy; Josiane Otto; Michel Poudenx; Eric Francois; René-Jean Bensadoun; Antoine Thyss; François Demard; Maurice Schneider
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

8.  Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history.

Authors:  M Morita; H Kuwano; S Ohno; K Sugimachi; Y Seo; H Tomoda; M Furusawa; T Nakashima
Journal:  Int J Cancer       Date:  1994-07-15       Impact factor: 7.396

9.  Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.

Authors:  Shu-Chun Chuang; Mia Hashibe; Ghislaine Scelo; David H Brewster; Eero Pukkala; Soren Friis; Elizabeth Tracey; Elisabete Weiderpass; Kari Hemminki; Sharon Tamaro; Kee-Seng Chia; Vera Pompe-Kirn; Erich V Kliewer; Jon M Tonita; Carmen Martos; Jon G Jonasson; Carolyn M Dresler; Paolo Boffetta; Paul Brennan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

10.  Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.

Authors:  Toshiki Matsubara; Kazuhiko Yamada; Aya Nakagawa
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

View more
  8 in total

1.  Treatment outcomes for one-stage concurrent surgical resection and reconstruction of synchronous esophageal and head and neck squamous cell carcinoma.

Authors:  Yu-Hsuan Lin; Chun-Yen Ou; Wei-Ting Lee; Yao -Chou Lee; Tzu -Yen Chang; Yi-Ting Yen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-22       Impact factor: 2.503

2.  Efficacy of Staged Treatment Strategy for Patients with Synchronous Double Cancers of the Esophagus and Head and Neck: A Retrospective Study.

Authors:  Akira Matsumoto; Masayuki Watanabe; Hironobu Shigaki; Koujiro Nishida; Shinji Mine; Takeshi Sano; Katsuhiko Yanaga
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

3.  Treatment of Squamous Cell Carcinoma of the Esophagus Synchronously Associated with Head and Neck Cancer.

Authors:  Masaru Morita; Akinori Egashira; Y U Nakaji; Masaki Kagawa; Masahiko Sugiyama; Daisuke Yoshida; Mitsuhiko Ota; Masahiko Ikebe; Muneyuki Masuda; Yojiro Inoue; Naonobu Kunitake; Yasushi Toh
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

4.  The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial.

Authors:  Goshi Nishimura; Daisuke Sano; Kenichiro Yabuki; Yasuhiro Arai; Yoshihiro Chiba; Teruhiko Tanabe; Nobuhiko Oridate
Journal:  JMIR Res Protoc       Date:  2017-12-05

5.  A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells.

Authors:  Peng Huang; Li-Ying Sun; Yan-Qiao Zhang
Journal:  Anal Cell Pathol (Amst)       Date:  2019-05-14       Impact factor: 2.916

6.  Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2.

Authors:  Yuko Kitagawa; Takashi Uno; Tsuneo Oyama; Ken Kato; Hiroyuki Kato; Hirofumi Kawakubo; Osamu Kawamura; Motoyasu Kusano; Hiroyuki Kuwano; Hiroya Takeuchi; Yasushi Toh; Yuichiro Doki; Yoshio Naomoto; Kenji Nemoto; Eisuke Booka; Hisahiro Matsubara; Tatsuya Miyazaki; Manabu Muto; Akio Yanagisawa; Masahiro Yoshida
Journal:  Esophagus       Date:  2018-08-31       Impact factor: 3.671

7.  A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer.

Authors:  Goshi Nishimura; Daisuke Sano; Yasuhiro Arai; Takashi Hatano; Hideaki Takahashi; Teruhiko Tanabe; Takashi Wada; Daiki Morishita; Nobuhiko Oridate
Journal:  Cancer Med       Date:  2019-10-08       Impact factor: 4.452

8.  Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma.

Authors:  Yuji Murakami; Yoichi Hamai; Manabu Emi; Jun Hihara; Nobuki Imano; Yuki Takeuchi; Ippei Takahashi; Ikuno Nishibuchi; Tomoki Kimura; Morihito Okada; Yasushi Nagata
Journal:  J Radiat Res       Date:  2018-09-01       Impact factor: 2.724

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.